Table 7.

The results of QoL assessment (EORTC QLQ-C30 symptom scales) in patient groups differing with respect to life orientation and the results of the analysis of variance.

QLQ-C30 Symptom Scales	Life Orientation (LOT-R)			ANOVA p
	Pessimistic Disposition 0–4 Sten Scores	Moderate Optimism 5–6 Sten Scores	Optimistic Disposition 7–10 Sten Scores
	n = 33	n = 71	n = 97
Fatigue (FA)				0.178
M ± SD	44.8 ± 23.2	40.8 ± 21.6	37.0 ± 21.5
Me (Q1; Q3)	44 [33; 56]	33 [22; 56]	33 [22; 44]
Min–Max	0–100	0–100	0–100
Nausea and vomiting (NV)				0.001
M ± SD	25.8 ± 32.6	18.8 ± 27.6	7.7 ± 19.7
Me (Q1; Q3)	0 [0; 50]	0 [0; 33]	0 [0; 0]
Min–Max	0–100	0–100	0–100
Pain (PA)				0.006
M ± SD	36.4 ± 24.1	31.9 ± 28.7	22.5 ± 21.4
Me (Q1; Q3)	33 [17; 50]	33 [17; 50]	17 [0; 33]
Min–Max	0–67	0–100	0–83
Dyspnoea (DY)				0.024
M ± SD	18.2 ± 27.8	19.5 ± 30.3	9.3 ± 19.7
Me (Q1; Q3)	0 [0; 33]	0 [0; 33]	0 [0; 0]
Min–Max	0–67	0–100	0–100
Sleep disturbance (SL)				0.325
M ± SD	36.5 ± 29.8	45.1 ± 28.2	38.1 ± 37.9
Me (Q1; Q3)	33 [0; 67]	33 [33; 67]	33 [0; 67]
Min–Max	0–100	0–100	0–100
Appetite loss (AP)				<0.001
M ± SD	27.3 ± 31.7	29.1 ± 29.8	12.0 ± 22.1
Me (Q1; Q3)	33 [0; 33]	33 [0; 67]	0 [0; 33]
Min–Max	0–100	0–100	0–100
Constipation (CO)				0.003
M ± SD	28.3 ± 26.5	25.8 ± 25.9	14.8 ± 22.0
Me (Q1; Q3)	33 [0; 33]	33 [0; 33]	0 [0; 33]
Min–Max	0–100	0–100	0–100
Diarrhoea (DI)				0.014
M ± SD	18.2 ± 32.4	12.7 ± 22.1	6.2 ± 16.2
Me (Q1; Q3)	0 [0; 33]	0 [0; 33]	0 [0; 0]
Min–Max	0–100	0–67	0–100
Financial difficulties (FI)				0.007
M ± SD	35.4 ± 33.3	37.1 ± 32.6	23.3 ± 25.2
Me (Q1; Q3)	33 [0; 33]	33 [0; 67]	33 [0; 33]
Min–Max	0–100	0–100	0–100

M—mean; SD—standard deviation; Me—median; Q₁—lower quartile; Q₃—upper quartile; Min—lowest value; Max—highest value; n—number; values in bold indicate statistical significance (p < 0.05).